Clinical Trial Update: Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY [Phase 4]

View source ↗

Summary

Phase 4 single-center open-label trial examining Preparation H for reducing erythema in relapsing multiple sclerosis patients treated with PLEGRIDY; study termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Plegridy (Peginterferon beta-1a)
• Preparation H

Snippet

Sponsor: NYU Langone Health | Conditions: Multiple Sclerosis | Phase 4 | Status: TERMINATED | Results posted: 2018-01-18